Advanced Search

Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2005 August;164(4) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2005 August;164(4):263-8



A Journal on Internal Medicine and Pharmacology

Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index

Frequency: Monthly

ISSN 0393-3660

Online ISSN 1827-1812


Gazzetta Medica Italiana Archivio per le Scienze Mediche 2005 August;164(4):263-8


Paroxysmal atrial fibrillation our experience in the Emergency Department of University Polyclinic A. Gemelli

Mazzone M., Portale G., Buccelletti F., La Sala M., Forte P., Ursella S., Testa A., Covino M., Pignataro G., Mancini F., Gentiloni Silveri N.

Departement of Emergency, University Cattolica del Sacro Cuore. Policlinico Universitario A. Gemelli, Rome

Aim. To underlie the most important implications of Paroxysmal Atrial Fibrillation, and describe the pathologies associated with a higher risk for the onset of this arrhythmia, and to individuate the relationship between age and duration of arrhythmic episode, and between sex and different age of development of PAF.
Methods. We studied 69 patients with diagnosis of Paroxysmal Atrial Fibrillation, at the admittance in our first aid station, between April-September 2001.
Results. The arrhythmia set in since less than 24 hours, so each patient underwent anti-arrhythmic, in order to try a cardioversion to a sinusal rhythm. We observed a higher relationship between PAF and arterial hypertension than with other pathologies; in female, the episodes are later then in male, arising in postmenopausal period (in male the higher incidence of the arrhythmia was between 20 and 40 years old). Patients in treatment with anti-arrhythmic drugs presented 1,83 episodes of PAF, in anamnesis, on average, while patients without therapy presented 1,36 episodes. Moreover, about 17% of patients, even though presented 1,5 episodes of PAF in anamnesis, didn’t have any risk factor.
Conclusion. It could be very interesting to study the relationship between the hormonal asset and the onset of PAF, in female, and to analyze the patients (mean age about 43 years old) developing atrial fibrillation but without risk factors. At last, we pointed out the lack of relationship between patient’s age and duration of arrhythmia, always justifying, if indicated, the treatment with anti-arrhythmic drugs in order to restore sinusal rhythm.

language: English


top of page